Personalized Pharmacotherapy for Patients with T2D

Saturday, May 14, 2022

11:00 AM – 12:00 PM

Location: Main Stage - Sapphire IJMN (Level 4)

Speaker(s)

Lawrence Blonde, MD, FACP, MACE
Physician
Ochsner Medical Center
New Orleans, Louisiana, United States

Disclosure: AstraZeneca (Self) : Consulting Fees (e.g., advisory boards) (Status: Terminated --- No activities in the past 24 months); Corcept (Self) : Consulting Fees (e.g., advisory boards) (Status: Ongoing); Gilead Sciences, Inc. (Self) : Consulting Fees (e.g., advisory boards) (Status: Ongoing), Honorarium (Status: Ongoing); Janssen () : Honorarium, speaker; Lyndra Therapeutics (Self) : Consulting Fees (e.g., advisory boards) (Status: Ongoing); Merck & Co (Self) : Consulting Fees (e.g., advisory boards) (Status: Ongoing); Novo Nordisk (Self) : Consulting Fees (e.g., advisory boards) (Status: Ongoing), Research Grant (Status: Ongoing); Salix (Self) : Consulting Fees (e.g., advisory boards) (Status: Ongoing); Sanofi (Self) : Consulting Fees (e.g., advisory boards) (Status: Ongoing), Honorarium (Status: Ongoing), Research Grant (Status: Ongoing)

PDF Slides
Guillermo E. Umpierrez, MD, MACP, CDCES, FACE
Professor of Medicine
Emory University
Atlanta, GA, United States

Disclosure: Astra Zeneca (Self) : Grant support to Emory University for investigator-initiated clinical studies (Status: Ongoing), University Grants/Research Support (Status: Ongoing); Dexcom (Self) : University Grants/Research Support (Status: Ongoing); Novo Nordisk (Self) : Grant support to Emory University for investigator-initiated clinical studies (Status: Terminated --- December 2020), University Grants/Research Support (Status: Terminated --- December 2020); Sanofi,Merck, Novo Nordisk, Astra Zeneca, Boehringer Ingelheim (Self) : Received grant support (to Emory university) for investigator-initiated research studies from Sanofi, Novo Nordisk, Astra Zeneca, Merck and Boehringer Ingelheim. (Status: Terminated --- January 2019), Research Grant (Status: Terminated --- January 2019)

PDF Slides

Moderator(s)

Susan L. Samson, MD, PhD, FRCPC, FACE
Senior Associate Consultant
Mayo Clinic Florida
Jacksonville, Florida, United States

Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Learning Objectives:

Learn AACE recommendations for the management of patients with diabetes
Review results of recent randomized control trials on the safety and efficacy of antidiabetic agents for cardiovascular and renal protection
Learn AACE recommendations for the management of obesity, hypertension, hyperlipidemia and cardiovascular risk factors in patients with diabetes

Participants should be aware of the following financial/non-financial relationships:

Lawrence Blonde, MD, FACP, MACE: AstraZeneca (Individual(s) Involved: Self): Consulting Fees (e.g., advisory boards); Corcept (Individual(s) Involved: Self): Consulting Fees (e.g., advisory boards); Gilead Sciences, Inc. (Individual(s) Involved: Self): Consulting Fees (e.g., advisory boards), Honorarium; Janssen: Honorarium, speaker; Lyndra Therapeutics (Individual(s) Involved: Self): Consulting Fees (e.g., advisory boards); Merck & Co (Individual(s) Involved: Self): Consulting Fees (e.g., advisory boards); Novo Nordisk (Individual(s) Involved: Self): Consulting Fees (e.g., advisory boards), Research Grant; Salix (Individual(s) Involved: Self): Consulting Fees (e.g., advisory boards); Sanofi (Individual(s) Involved: Self): Consulting Fees (e.g., advisory boards), Honorarium, Research Grant

Guillermo E. Umpierrez, MD, MACP, CDCES, FACE: Astra Zeneca (Individual(s) Involved: Self): Grant support to Emory University for investigator-initiated clinical studies, University Grants/Research Support; Dexcom (Individual(s) Involved: Self): University Grants/Research Support; Novo Nordisk (Individual(s) Involved: Self): Grant support to Emory University for investigator-initiated clinical studies, University Grants/Research Support; Sanofi,Merck, Novo Nordisk, Astra Zeneca, Boehringer Ingelheim (Individual(s) Involved: Self): Received grant support (to Emory university) for investigator-initiated research studies from Sanofi, Novo Nordisk, Astra Zeneca, Merck and Boehringer Ingelheim., Research Grant

Susan L. Samson, MD, PhD, FRCPC, FACE: I do not have any relevant financial / non-financial relationships with any proprietary interests.